Used as a key intermediate in the synthesis of potent kinase inhibitors, particularly in the development of anticancer agents. Its structure enables selective binding to specific enzyme targets involved in tumor growth and signal transduction pathways. Commonly employed in pharmaceutical research for optimizing drug candidates targeting solid tumors and hematological malignancies. Also utilized in structure-activity relationship (SAR) studies to enhance potency, selectivity, and metabolic stability of investigational drugs.